Israeli Prime Minister Benjamin Netanyahu expressed skepticism during his meeting with President Trump about the chance of a deal with Iran and discussed increasing economic pressure on Iran "through kinetic and non-kinetic means," a senior Israeli official said in a briefing with reporters. Why it matters: Tuesday's meeting was the first between Netanyahu and Trump since the start of the war on Feb. 28. It came as Trump is still trying to reach a deal with Iran but also considering a return to major combat operations. - Several hours after the sitdown, Iran launched a missile attack on an American base in Jordan for the first time since Trump paused U.S. strikes in Iran on Friday. - Trump vowed a serious response during an interview…
House Democrats' internal split over a vote to cut off U.S. aid to Israel has extended to leadership, with Minority Leader Hakeem Jeffries (D-N.Y.) and Minority Whip Katherine Clark (D-Mass.) planning to vote differently. Why it matters: Such a divergence between the caucus' top two leaders is exceedingly rare and underscores just how much anxiety this vote is giving some in the party. - Many House Democrats have substantive misgivings but plan to vote for the measure anyway due to growing political pressure from the left. - "There are going to be people within our own party trying to drag us over the coals," one House Democrat told Axios on the condition of anonymity to speak candidly about the political pressures undergirding their…
The New York Democrat and minority leader indicated that he would not seek to persuade other Democrats to vote against the measure, which has divided the party amid a deep rift over support for Israel.
Through an innovative program, parents in Senegal had easy access to a therapeutic food that's a boon for malnourished kids. Now there are shortages. Health specialists say U.S. aid cuts are to blame.
A new twice-yearly HIV prevention injection could transform South Africa's fight against the epidemic — but U.S. aid cuts and limited doses threaten to slow its impact.
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.